|
| 產(chǎn)地 | 進口、國產(chǎn) |
| 品牌 | 上海莼試 |
| 保存條件 | Store at -20 °C |
| 貨號 | CS10670 |
| 應(yīng)用范圍 | WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 |
| CAS編號 | |
| 抗體名 | Anti-PPAR gamma |
| 克隆性 | |
| 靶點 | 詳見說明書 |
| 適應(yīng)物種 | 詳見說明書 |
| 形態(tài) | 詳見說明書 |
| 宿主 | 詳見說明書 |
| 亞型 | IgG |
| 標(biāo)識物 | 詳見說明書 |
| 濃度 | 1mg/1ml% |
| 免疫原 | KLH conjugated synthetic peptide derived from human PP-2A C-terminus |
中文名稱 過氧化酶活化增生受體γ抗體（PPAR-γ）規(guī)格
英文名稱 Anti-PPAR gamma
別 名 PPAR Gamma; CIMT1; HUMPPARG; NR1C3; Nuclear receptor subfamily 1 group C member 3; PAX8/PPARG Fusion Gene; Peroxisome Proliferator Activated Receptor gamma; PPAR gamma; PPARG; PPARG1; PPARG2; PPARG3; CIMT1; GLM1; HUMPPARG; NR1C3; Nuclear receptor subfamily 1 group C member 3; PAX8/PPARG Fusion Gene; Peroxisome proliferator activated nuclear receptor gamma variant 1; Peroxisome proliferator activated receptor gamma 1; Peroxisome Proliferator Activated Receptor gamma; Peroxisome proliferator-activated receptor gamma; PPAR gamma; PPAR-gamma; PPARG; PPARG_HUMAN; PPARG1; PPARG2; PPARG3; PPAR gamma 1; PPAR gamma 2; PPAR gamma 3; PPAR gamma-1; PPAR gamma-2; PPAR gamma-3.
產(chǎn)品屬性：
過氧化酶活化增生受體γ抗體（PPAR-γ）規(guī)格 濃 度 1mg/1ml
規(guī) 格 0.1ml/100μg 0.2ml/200μg
抗體來源 Rabbit
克隆類型 polyclonal
交叉反應(yīng) Human, Mouse, Rat, Chicken, Pig, Cow, Rabbit, Sheep
產(chǎn)品類型 一抗
研究領(lǐng)域 免疫學(xué) 信號轉(zhuǎn)導(dǎo) 轉(zhuǎn)錄調(diào)節(jié)因子 激酶和磷酸酶 病
蛋白分子量 predicted molecular weight: 57kDa
性 狀 Lyophilized or Liquid
免 疫 原 KLH conjugated synthetic peptide derived from human PPAR Gamma
亞 型 IgG
純化方法 affinity purified by Protein A
儲 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide
過氧化酶活化增生受體γ抗體（PPAR-γ）規(guī)格 產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
（石蠟切片需做抗原修復(fù)）
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
產(chǎn)品介紹 The PPAR gamma antibody mainly is exist in the white fat organization, the fat for the PPAR gamma is born, blood sugar stability, the disease respond, the artery gruel kind hardens to rise the important function with the tumor occurrence of etc. all, but concerning the PPAR gamma to bone of function is a new research heat to order in recent years.A PPAR of many researches report gamma was go together with the body is after activate can the function promote many capable cells divided to increase to living but repress the ossification cell to divide to cause the bone measure the decrease or bone softs toward the fat cell in the marrow, the PPAR gamma promotes the ability and bones that the fat cell divide metabolize closely related, the performance is increasing along with the growth marrow fat content of the age, the ossification cell metabolism the outcome reduce, the different construction PPAR gamma 2 have the important function.
Function : Receptor that binds peroxisome proliferators such as hypolipidemic drugs and fatty acids. Once activated by a ligand, the receptor binds to a promoter element in the gene for acyl-CoA oxidase and activates its transcription. It therefore controls the peroxisomal beta-oxidation pathway of fatty acids. Key regulator of adipocyte differentiation and glucose homeostasis.
Subunit : Forms a heterodimer with the retinoic acid receptor RXRA called adipocyte-specific transcription factor ARF6. Interacts with NCOA6 coactivator, leading to a strong increase in transcription of target genes. Interacts with coactivator PPARBP, leading to a mild increase in transcription of target genes. Interacts with FAM120B. Interacts with PRDM16 (By similarity). Interacts with NOCA7 in a ligand-inducible manner. Interacts with NCOA1 LXXLL motifs. Interacts with TGFB1I1. Interacts with DNTTIP2. Interacts with PRMT2.
Subcellular Location : Nucleus.
DISEASE : Note=Defects in PPARG can lead to type 2 insulin-resistant diabetes and hyptertension. PPARG mutations may be associated with colon cancer.
Defects in PPARG may be associated with susceptibility to obesity (OBESITY) [MIM:601665]. It is a condition characterized by an increase of body weight beyond the limitation of skeletal and physical requirements, as the result of excessive accumulation of body fat.
Defects in PPARG are the cause of familial partial lipodystrophy type 3 (FPLD3) [MIM:604367]. Familial partial lipodystrophies (FPLD) are a heterogeneous group of genetic disorders characterized by marked loss of subcutaneous (sc) fat from the extremities. Affected individuals show an increased preponderance of insulin resistance, diabetes mellitus and dyslipidemia.
Genetic variations in PPARG can be associated with susceptibility to glioma type 1 (GLM1) [MIM:137800]. Gliomas are central nervous system neoplasms derived from glial cells and comprise astrocytomas, glioblastoma multiforme, oligodendrogliomas, and ependymomas. Note=Polymorphic PPARG alleles have been found to be significantly over-represented among a cohort of American patients with sporadic glioblastoma multiforme suggesting a possible contribution to disease susceptibility.
Similarity : Belongs to the nuclear hormone receptor family. NR1 subfamily.
Contains 1 nuclear receptor DNA-binding domain.
Database links : UniProtKB/Swiss-Prot: P37231.3
類固醇受體（Steroid Receptors）
過氧化物酶體增殖物激活受體γ（PPARγ）主要存在于白色脂肪組織，PPARγ對于脂肪生成、穩(wěn)定、反應(yīng)、和等的發(fā)生都起到重要的作用。主要在脂肪細胞內(nèi)表達。PPARγ是噻唑烷二酮類藥物（TZDs）作用的藥靶，又是脂肪細胞分化的重要調(diào)節(jié)因子。經(jīng)研究發(fā)現(xiàn)，PPARγ在及抵抗的機制中具有十分重要的意義，是的重要藥靶。
過氧化物酶體增殖物激活受體γ（PPARγ）屬Ⅱ型核受體超家族成員，主要在脂肪細胞內(nèi)表達。PPARγ是噻唑烷二酮類藥物（TZDs）作用的藥靶，又是脂肪細胞分化的重要調(diào)節(jié)因子?，F(xiàn)有研究（包括一次于美國加州大學(xué)進行的研究）發(fā)現(xiàn)PPARγ在及抵抗的機制中具有十分重要的意義，是的重要藥靶。目前，該受體蛋白質(zhì)水平的篩選模式已經(jīng)建立，并正在建立該受體的報告基因的細胞水平篩選評價模式。
實驗流程：
全、新、優(yōu)、品、好四大特點：
過氧化酶活化增生受體γ抗體（PPAR-γ）規(guī)格 全：公司提供上萬種產(chǎn)品，涵蓋了生物試劑，elisa試劑盒，標(biāo)準(zhǔn)品，培養(yǎng)基，原裝耗材，抗體、培養(yǎng)基、ATCC細胞等，基本上各種科研所需產(chǎn)品在我司都能找到。
新：產(chǎn)品更新速度較快，基本上每周都有新產(chǎn)品出現(xiàn)。
優(yōu)：產(chǎn)品質(zhì)量好，投訴比較少。
好：我公司具有優(yōu)質(zhì)的技術(shù)團隊，產(chǎn)品一旦售出，實驗過程中遇到困難可提供在線技術(shù)咨詢。使您使用產(chǎn)品時沒有任何的后顧之憂。
技術(shù)外包服務(wù):
★過氧化酶活化增生受體γ抗體（PPAR-γ）規(guī)格 分子生物學(xué)：質(zhì)粒抽提、PCR、Q-PCR、RT-PCR、分子生物學(xué)：基因合成、引物合成、基因測序、載體構(gòu)建等
★蛋白工程：原核、哺乳動物蛋白表達系統(tǒng)等
★病毒包裝：腺病毒、慢病毒等
★抗體工程：磁珠分選、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等
★細胞工程：細胞表型分析(凋亡、增殖、周期、遷移、侵襲、修復(fù)、克隆形成)、細胞培養(yǎng)、細胞膜制備、穩(wěn)定細胞株構(gòu)建、細胞RNAi技術(shù)等等。
正在熱銷的相關(guān)產(chǎn)品：
Anti-CCK8/FITC 熒光素標(biāo)記膽囊收縮素/縮膽囊素抗體(八肽)Multi-class antibodies規(guī)格： 0.2ml
Anti-HER2 receptor/FITC 熒光素標(biāo)記抗HER2受體抗體IgGMulti-class antibodies規(guī)格： 0.2ml
Rhesus antibody Rh CEA(B5) 癌胚抗原單克隆抗體(檢測) 規(guī)格 0.1ml
SREBP-1(Sterol Regulatory Element Binding Protein-1) 固醇調(diào)節(jié)元件結(jié)合蛋白1抗原 0.5mg
ICAM-2 英文名稱： 細胞間粘附分子-2抗體 0.2ml
Rhesus antibody Rh Thy-1/CD90/ Thy1.1 CD90抗體 規(guī)格 0.1ml
Anti-HER2 receptor/FITC 熒光素標(biāo)記抗HER2受體抗體IgGMulti-class antibodies規(guī)格： 0.2ml
Anti-KT3 tag/FITC 熒光素標(biāo)記KT3 tag標(biāo)簽抗體IgGMulti-class antibodies規(guī)格： 0.2ml
Anti-Phospho-Smad1/5 (Ser463/465)/FITC 熒光素標(biāo)記磷酸化細胞信號轉(zhuǎn)導(dǎo)分子Smad-1/5抗體IgGMulti-class antibodies規(guī)格： 0.2ml
Rhesus antibody Rh Aldolase A 醛縮酶A抗體 規(guī)格 0.1ml
Rabbit Anti-human IgG/Cy3 Cy3標(biāo)記的兔抗人IgG 0.1ml
Phospho-Glycogen synthase 1(Ser645) 英文名稱： 磷酸化葡萄糖合成酶1抗體 0.1ml
Rhesus antibody Rh Rabbit Anti-Guinea pig IgG/PE-Cy3 PE-Cy3標(biāo)記的兔抗豚鼠IgG 規(guī)格 0.1ml
Anti-Phospho-Smad1/5 (Ser463/465)/FITC 熒光素標(biāo)記磷酸化細胞信號轉(zhuǎn)導(dǎo)分子Smad-1/5抗體IgGMulti-class antibodies規(guī)格： 0.2ml
BF(Human factor B) ELISA Kit 人B因子Multi-class antibodies規(guī)格： 48T
Anti-Rad52 Rad52抗體Multi-class antibodies規(guī)格： 0.1ml
Rhesus antibody Rh HAPLN2 透明質(zhì)酸及粘蛋白2抗體 規(guī)格 0.2ml
HPA(Human Heparanase) ELISA kit 人乙酰肝素酶 96T
phospho-P53(Thr55) 英文名稱： 磷酸化抑制基因P53抗體 0.1ml
BCAT1 英文名稱： 胞漿支鏈基酸酸轉(zhuǎn)酶抗體 0.1ml
Anti-Rad52 Rad52抗體Multi-class antibodies規(guī)格： 0.1ml
CL-0184PANC-1(人*癌細胞)5×106cells/瓶×2
TNK2 Others Human 人 ACK1 / TNK2 桿狀病毒-昆蟲細胞裂解液 (陽性對照)
人上皮細胞裂解物HMEpiCL
HCC1428細胞，人癌細胞 人小細胞細胞,LTEP-P細胞 晶狀體上皮細胞Many types of cells包裝：5 × 105次方(1ml)
狗肺成纖維樣細胞;DogL1
TNFRSF4 Others Human 人 TNFRSF4 / CD134 人細胞裂解液 (陽性對照)
CL-0183PA317(小鼠成纖維細胞)5×106cells/瓶×2
SELP Others Human 人 SELP / selectin P / P-selectin 人細胞裂解液 (陽性對照)
小鼠腸粘膜上皮細胞完全培養(yǎng)基 100mL
3D4/21豬肺泡巨噬細胞 Porcine alveolar macrophage 3D4/21 1640+10% FBS+0.1mM NEAA+1mM 酸
CF Protein Mouse 重組小鼠 CF / Ciliary Neuroophic Factor 蛋白 (His 標(biāo)簽)
RBL-1(大鼠嗜堿性粒細胞性細胞) 5×106cells/瓶×2 PC-3(人細胞)
過氧化酶活化增生受體γ抗體（PPAR-γ）規(guī)格 CD160 Others Cynomolgus 食蟹猴 CD160 人細胞裂解液 (陽性對照)
小鼠細胞;CT26.WT [CT26WT]
CM-M013小鼠肺大內(nèi)皮細胞完全培養(yǎng)基100mL
KYSE 150細胞，人食管鱗癌 人神經(jīng)細胞,U251細胞 兔角膜前基質(zhì)層成纖維細胞;RCFBF
CCD-1095Sk(人浸潤性導(dǎo)管癌旁皮膚細胞) 5×106cells/瓶×2
CD34 Others Human 人 CD34 人細胞裂解液 (陽性對照)
|
|
|
|
